Gong, Jia-Nan https://orcid.org/0000-0003-4977-9775
Djajawi, Tirta M.
Moujalled, Donia M. https://orcid.org/0000-0002-1076-3496
Pomilio, Giovanna
Khong, Tiffany
Zhang, Li-Ping
Fedele, Pasquale L.
Low, Michael S.
Anderson, Mary Ann
Riffkin, Christopher D.
White, Christine A. https://orcid.org/0000-0001-8033-9140
Lan, Ping
Lessene, Guillaume https://orcid.org/0000-0002-1193-8147
Herold, Marco J. https://orcid.org/0000-0001-7539-7581
Strasser, Andreas https://orcid.org/0000-0002-5020-4891
Spencer, Andrew
Grigoriadis, George
Wei, Andrew H.
van Delft, Mark F. https://orcid.org/0000-0002-3866-4318
Roberts, Andrew W. https://orcid.org/0000-0002-7341-5720
Huang, David C. S. https://orcid.org/0000-0002-3101-4873
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1043149, 1016701, 1113133)
Leukemia and Lymphoma Society (7001-013, 7015-18)
Article History
Received: 5 July 2024
Revised: 23 January 2025
Accepted: 18 March 2025
First Online: 9 April 2025
Competing interests
: JNG, TMD, DMM, GP, MAA, CDR, CAW, GL, MJH, A Strasser, AHW, MFvD, AWR and DCSH are former or current employees of the Walter and Eliza Hall Institute which receives milestone and royalty payments related to venetoclax. AWR has received research funding from AbbVie. DCSH has received research funding from Genentech and Servier.
: All methods were performed in accordance with the relevant guidelines and regulations. Peripheral blood or bone marrow samples were collected from patients after written informed consent was obtained. Studies were performed with the approval of the institutional Human Research Ethics Committees at WEHI (approval 05/04), the Royal Melbourne Hospital, the Monash Medical Centre, or the Alfred Hospital. All animal experimentation was approved by the Walter and Eliza Hall Institute Animal Ethics Committee (AEC approval 2017.007) and conducted according to its guidelines.